Opioid-sparing effect of cannabinoids for analgesia: an updated systematic review and meta-analysis of preclinical and clinical studies

Cannabinoid co-administration may enable reduced opioid doses for analgesia. This updated systematic review on the opioid-sparing effects of cannabinoids considered preclinical and clinical studies where the outcome was analgesia or opioid dose requirements. We searched Scopus, Cochrane Central Regi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Neuropsychopharmacology (New York, N.Y.) N.Y.), 2022-06, Vol.47 (7), p.1315-1330
Hauptverfasser:	Nielsen, Suzanne, Picco, Louisa, Murnion, Bridin, Winters, Bryony, Matheson, Justin, Graham, Myfanwy, Campbell, Gabrielle, Parvaresh, Laila, Khor, Kok-Eng, Betz-Stablein, Brigid, Farrell, Michael, Lintzeris, Nicholas, Le Foll, Bernard
Format:	Artikel
Sprache:	eng
Schlagworte:	Analgesia Analgesics, Opioid Cannabinoids Cannabinoids - pharmacology Cannabinoids - therapeutic use Chronic Pain - drug therapy Clinical trials Drug abuse Humans Meta-analysis Morphine Morphine - therapeutic use Narcotics Opioid-Related Disorders - drug therapy Opioids Pain Pain perception Systematic review Tetrahydrocannabinol
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!